HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
N Colombo Selected Research
N Colombo Research Topics
Disease
29
Ovarian Neoplasms (Ovarian Cancer)
12/2023 - 06/2000
19
Neoplasms (Cancer)
02/2024 - 06/2001
7
Ovarian Epithelial Carcinoma
10/2022 - 10/2000
6
Disease Progression
10/2022 - 01/2011
5
Endometrial Neoplasms (Endometrial Cancer)
02/2024 - 03/2013
4
Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2016 - 04/2009
4
Carcinoma (Carcinomatosis)
04/2009 - 10/2000
3
Neutropenia
07/2013 - 03/2002
2
Granulosa Cell Tumor
05/2021 - 01/2020
2
Nausea
07/2013 - 03/2002
2
Seizures (Absence Seizure)
02/2007 - 01/2000
2
Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2001 - 06/2001
2
Vulvar Neoplasms (Vulvar Cancer)
06/2001 - 01/2000
1
Turcot syndrome
02/2024
1
Microsatellite Instability
02/2024
1
Genomic Instability
01/2023
1
Hypertension (High Blood Pressure)
12/2019
1
Thrombocytopenia (Thrombopenia)
01/2018
1
Hematologic Neoplasms (Hematological Malignancy)
06/2015
1
Alopecia (Baldness)
07/2013
1
Headache (Headaches)
07/2013
1
Atrial Fibrillation
08/2012
1
Pain (Aches)
06/2009
1
Residual Neoplasm
04/2009
1
Sudden Death
01/2009
1
Cardiotoxicity
01/2009
1
Cardiomyopathies (Cardiomyopathy)
01/2009
1
Long QT Syndrome
01/2009
1
Torsades de Pointes (Torsade de Pointes)
01/2009
1
Supraventricular Tachycardia
01/2009
1
Premature Cardiac Complexes (Extrasystoles)
01/2009
1
Fever (Fevers)
02/2008
1
Dementia (Dementias)
01/2008
1
Frontal Lobe Epilepsy (Epilepsy, Supplementary Motor)
02/2007
Drug/Important Bio-Agent (IBA)
20
Platinum
IBA
12/2023 - 10/2000
11
Paclitaxel (Taxol)
FDA Link
Generic
01/2021 - 06/2000
7
Poly(ADP-ribose) Polymerase Inhibitors
IBA
12/2023 - 01/2018
6
olaparib
IBA
12/2023 - 01/2020
6
Cisplatin (Platino)
FDA Link
Generic
04/2009 - 06/2000
4
liposomal doxorubicin (Doxil)
FDA Link
01/2023 - 01/2011
4
Carboplatin (JM8)
FDA Link
Generic
01/2023 - 10/2000
3
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
12/2023 - 01/2020
3
Trabectedin
IBA
01/2023 - 01/2011
3
1-dodecylpyridoxal (PLD)
IBA
01/2023 - 01/2011
2
Bevacizumab (Avastin)
FDA Link
01/2023 - 12/2019
2
Biomarkers (Surrogate Marker)
IBA
01/2023 - 01/2022
2
niraparib
IBA
01/2020 - 01/2018
2
Cyclophosphamide (Cytoxan)
FDA Link
Generic
06/2015 - 03/2002
2
Ifosfamide
FDA Link
Generic
04/2009 - 02/2008
2
Doxorubicin (Adriamycin)
FDA Link
Generic
03/2002 - 10/2000
2
Bleomycin (Blenoxane)
FDA Link
Generic
07/2001 - 06/2001
1
N 563
IBA
02/2024
1
Matrix Gla Protein
IBA
01/2023
1
Carbohydrates
IBA
01/2022
1
Mucin-1 (CA 15-3 Antigen)
IBA
01/2022
1
Monoclonal Antibodies
IBA
01/2022
1
Epitopes
IBA
01/2022
1
Tablets
IBA
01/2022
1
mirvetuximab soravtansine
IBA
01/2021
1
Indocyanine Green (Cardio-Green)
FDA Link
Generic
01/2021
1
Topotecan (Hycamtin)
FDA Link
Generic
01/2021
1
veliparib
IBA
01/2020
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
12/2019
1
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
12/2019
1
pazopanib
FDA Link
11/2019
1
pembrolizumab
IBA
01/2019
1
mesoglycan
IBA
11/2016
1
ZD4054
IBA
07/2013
1
ridaforolimus
IBA
03/2013
1
TOR Serine-Threonine Kinases
IBA
03/2013
1
Quinidine (Chinidin)
FDA Link
Generic
08/2012
1
Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)
IBA
01/2011
1
ST 1481 (Gimatecan)
IBA
04/2010
1
Taxoids (Taxanes)
IBA
04/2010
1
Analgesics (Analgesic Drugs)
IBA
06/2009
1
Antiemetics
IBA
06/2009
1
Drug Combinations
IBA
04/2009
1
Anthracyclines
IBA
01/2009
1
Epirubicin (Ellence)
FDA Link
Generic
02/2008
1
Colony-Stimulating Factors (Colony Stimulating Factor)
IBA
02/2008
1
Buffers
IBA
01/2008
1
Complementary DNA (cDNA)
IBA
06/2007
1
Fenretinide
IBA
06/2007
1
Retinoids
IBA
06/2007
1
Small Interfering RNA (siRNA)
IBA
06/2007
1
Anticonvulsants (Antiepileptic Drugs)
IBA
02/2007
Therapy/Procedure
25
Drug Therapy (Chemotherapy)
12/2023 - 10/2000
10
Therapeutics
12/2023 - 10/2000
3
Laparotomy
05/2021 - 06/2009
3
Adjuvant Chemotherapy
06/2014 - 11/2003
3
Combination Drug Therapy (Combination Chemotherapy)
12/2013 - 06/2001
2
Drug Tapering
01/2022 - 01/2018
2
Neoadjuvant Therapy
09/2016 - 07/2013
2
Palliative Care (Palliative Therapy)
04/2013 - 06/2001
1
Immunotherapy
02/2024
1
Maintenance Chemotherapy
12/2023
1
Hysterectomy
09/2016
1
Radiotherapy
01/2016
1
Pelvic Exenteration
07/2013
1
Conservative Treatment
01/2013